Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2007; 13(48): 6575-6580
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6575
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6575
Table 4 Influence of SFAP on serum sIL-2R and Ig levels in cyclophosphamide-treated mice (mean ± SD)
Group | Dose(mg/kg) | sIL-2R (pmol/L) | IgA(g/L) | IgG(g/L) | IgM(g/L) |
NS control | 0 | 30.4 ± 2.5 | 2.92 ± 0.84 | 8.07 ± 0.94 | 2.31 ± 0.51 |
CTX control | 10 | 77.8 ± 8.5b | 1.77 ± 0.14b | 6.35 ± 0.63b | 1.68 ± 0.14a |
SFAP + CTX | 50 + 10 | 75.9 ± 6.4 | 2.02 ± 0.31 | 6.87 ± 0.34 | 1.82 ± 0.27 |
SFAP + CTX | 100 + 10 | 59.6 ± 6.1d | 2.31 ± 0.48c | 7.70 ± 0.37d | 2.16 ± 0.33d |
SFAP + CTX | 200 + 10 | 52.7 ± 5.7d | 3.11 ± 0.72d | 7.87 ± 0.59d | 2.49 ± 0.46d |
- Citation: Chen HS, Chen J, Cui DL, Zheng YY, Xu AH, Chen G, Jia LC. Effects of a Shuangling Fuzheng anticancer preparation on the proliferation of SGC-7901 cells and immune function in a cyclophosphamide-treated murine model. World J Gastroenterol 2007; 13(48): 6575-6580
- URL: https://www.wjgnet.com/1007-9327/full/v13/i48/6575.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i48.6575